MS relapses are more common in spring and summer, coinciding with warmer, drier weather and atmospheric changes, a study ...

The CEMIP enzyme inhibits the growth of oligodendrocytes and may serve as a therapeutic target to boost myelin repair in MS, ...

Taking lipoic acid failed to ease progressive MS symptoms in a clinical trial, but the antioxidant showed signs of slowing ...

A clinical trial testing whether music therapy can make botulinum toxin injections for spasticity more comfortable is ...

Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...

A new analysis found that eating both oily fish and wholemeal/wholegrain bread may help lower one's risk of developing ...

As she prepares to change medications for her MS, columnist Leigh Anne Nelson explores the U.S. government’s registry on ...

Gadoquatrane showed pediatric safety and pharmacokinetic profiles similar to adults in a study, supporting use as a low-dose ...

Disease-modifying therapies for MS that prevent brain volume loss are linked to reduced long-term disability, new data show.

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

Columnist Desiree Lama is learning how to manage her sensitivity to cold weather with MS now that temperatures in Texas are ...

Columnist Susan Payrovi credits hand weakness and MS with the pivots in her medical career that now allow her to focus on ...